How much funding has CAPSULOMICS INC raised?

CAPSULOMICS INC has raised $3.0M in total funding, most recently a seed round.

Who are CAPSULOMICS INC's investors?

CAPSULOMICS INC's investors include TEDCO, Gaingels.

When was CAPSULOMICS INC founded?

CAPSULOMICS INC was founded in 2020.

Where is CAPSULOMICS INC headquartered?

CAPSULOMICS INC is headquartered in WILMINGTON, Delaware, United States.

What industry is CAPSULOMICS INC in?

CAPSULOMICS INC operates in Biotech, Healthcare.

How many employees does CAPSULOMICS INC have?

CAPSULOMICS INC has 1-10 employees.

CAPSULOMICS INC

WILMINGTON, United States · Founded 2020 · $3.0M raised

Biotech

Healthcare

Headquarters: WILMINGTON, Delaware
Employees: 1–10
Founded: 2020
Business Model: B2B

Total Funding: $3.0M
Last Round: $3.0M SeedMar 2023
Rounds: 1

About

Capsulomics (now operating as Previse) is a molecular diagnostics company focused on early detection of upper gastrointestinal cancer, specifically developing Esopredict, an epigenetic test to predict cancer progression risk in Barrett's esophagus patients. The company was spun out of Johns Hopkins University School of Medicine and has received NIH funding to commercialize its biomarker technology. In May 2025, Previse was acquired by Castle Biosciences.

Summary

CAPSULOMICS INC is a Biotech company based in WILMINGTON, United States, founded in 2020. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Mar 2023. Investors include TEDCO and Gaingels.